Ledger.Open graph →

SEC Form D · filed April 13, 2012

Morria Biopharmaceuticals PLC

Offering

$1.1M

Sold

—

Exemption

—

Industry

Biotechnology

Location

LONDON, United Kingdom

Type

—

People & firms on this filing (14)

Saul Yedgar · Jerusalem, L3Exec · Director Mark Cohen · New York, NYDirector Terry L. Meadors · Cincinnati, OHDirector Yuval Cohen · Bethesda, MDExec · Director Dov Elefant · New York, NYExec Maziyar Yousefizad · Gainesville, FLDirector Thomas Alessi · Hayward, CAExec · Director Coke Reed · Austin, TXDirector Yuval Cohen · New York, NYExec · Director Dov Elefant · London, United KingdomExec Joe Bondi · Collegeville, PAExec Gilead Raday · Kefar-Uria, L3Director David Sidransky · Somerset, NJDirector Amos Eiran · Herzeliya, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗